PT2425251T - Meios e métodos para a determinação da quantidade de polipéptido de neurotoxina e das suas atividades catalítica e proteolítica - Google Patents

Meios e métodos para a determinação da quantidade de polipéptido de neurotoxina e das suas atividades catalítica e proteolítica

Info

Publication number
PT2425251T
PT2425251T PT107140378T PT10714037T PT2425251T PT 2425251 T PT2425251 T PT 2425251T PT 107140378 T PT107140378 T PT 107140378T PT 10714037 T PT10714037 T PT 10714037T PT 2425251 T PT2425251 T PT 2425251T
Authority
PT
Portugal
Prior art keywords
catalytic
determination
methods
amount
neurotoxin polypeptide
Prior art date
Application number
PT107140378T
Other languages
English (en)
Inventor
Pfeil Michael
Friedrich Josef
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of PT2425251T publication Critical patent/PT2425251T/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT107140378T 2009-04-27 2010-04-23 Meios e métodos para a determinação da quantidade de polipéptido de neurotoxina e das suas atividades catalítica e proteolítica PT2425251T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21465009P 2009-04-27 2009-04-27
EP09158788 2009-04-27

Publications (1)

Publication Number Publication Date
PT2425251T true PT2425251T (pt) 2017-11-27

Family

ID=41066304

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107140378T PT2425251T (pt) 2009-04-27 2010-04-23 Meios e métodos para a determinação da quantidade de polipéptido de neurotoxina e das suas atividades catalítica e proteolítica

Country Status (15)

Country Link
US (2) US8663942B2 (pt)
EP (1) EP2425251B1 (pt)
JP (1) JP5689113B2 (pt)
KR (1) KR101818777B1 (pt)
CN (1) CN102414564B (pt)
AU (1) AU2010243692B2 (pt)
BR (1) BRPI1015311B1 (pt)
CA (1) CA2757637C (pt)
ES (1) ES2647243T3 (pt)
HK (1) HK1169171A1 (pt)
IL (1) IL215441A (pt)
MX (1) MX2011011045A (pt)
PT (1) PT2425251T (pt)
RU (1) RU2545783C9 (pt)
WO (1) WO2010124998A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012020057A1 (en) * 2010-08-11 2012-02-16 Merz Pharma Gmbh & Co. Kgaa Selective manufacture of recombinant neurotoxin polypeptides
JP6156954B2 (ja) * 2012-11-21 2017-07-05 イプセン バイオイノベーション リミテッド タンパク分解性にプロセシングされたポリペプチドの製造方法
LT3014267T (lt) * 2013-06-28 2018-12-10 Merz Pharma Gmbh & Co. Kgaa Priemonės ir būdai, skirti neurotoksinių polipeptidų nustatymui
EP3221699B1 (en) 2014-11-21 2020-06-17 Merz Pharma GmbH & Co. KGaA Methods for the determination of the biological activities of neurotoxin polypeptides
RU2694964C2 (ru) * 2017-12-19 2019-07-19 ФЕДЕРАЛЬНОЕ АГЕНТСТВО ПО ТЕХНИЧЕСКОМУ РЕГУЛИРОВАНИЮ И МЕТРОЛОГИИ (Росстандарт) Способ измерений каталитической активности (каталитической концентрации) ферментов с использованием методов масс-спектрометрии и спектрофотометрии с предварительной идентификацией целевого аналита и определением чистоты веществ
MX2020007444A (es) 2018-01-12 2020-09-14 Genzyme Corp Metodos para la cuantificacion de polipeptidos.
US20220160874A1 (en) * 2019-04-03 2022-05-26 Technical University Of Denmark Neurotrophic factor protein conjugates and related embodiments

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
JPH05501351A (ja) * 1989-08-16 1993-03-18 カイロン　コーポレイション プロホルモンタンパク質に対する開裂部位阻止抗体及びその使用
GB9411138D0 (en) * 1994-06-03 1994-07-27 Microbiological Res Authority Toxin assay
ES2277854T5 (es) * 1999-08-25 2011-02-04 Allergan, Inc. Neurotoxinas recombinantes activables.
US6678651B2 (en) * 2000-09-15 2004-01-13 Mindspeed Technologies, Inc. Short-term enhancement in CELP speech coding
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US20060063221A1 (en) * 2004-09-21 2006-03-23 Williams Dudley J Lanthanide-based substrates and methods for determining clostridial toxin activity
US8137924B2 (en) * 2003-12-19 2012-03-20 Wisconsin Alumni Research Foundation Method and compositions for detecting botulinum neurotoxin
FR2869908B1 (fr) * 2004-05-05 2006-07-28 Pharmaleads Substrat peptidique reconnu par la toxine botulique de type a, bont/a et son utilisation pour detecter et/ou doser ladite toxine ou des inhibiteurs de son activite
CA2686642A1 (en) * 2007-06-01 2008-12-04 Merz Pharma Gmbh & Co. Kgaa Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin
US7732579B2 (en) * 2007-06-13 2010-06-08 The United States Of America As Represented By The Secretary Of Agriculture High-affinity monoclonal antibodies for botulinum toxin type A
US8486422B2 (en) * 2007-07-26 2013-07-16 Allergan, Inc. Methods of activating clostridial toxins
CN101386648B (zh) * 2008-09-25 2012-05-30 中国人民解放军军事医学科学院微生物流行病研究所 抗b型肉毒神经毒素中和性单克隆抗体、其制备方法及用途
AU2010214834B2 (en) * 2009-02-19 2016-04-14 Merz Pharma Gmbh & Co. Kgaa Means and methods for manufacturing highly pure neurotoxin

Also Published As

Publication number Publication date
RU2011147994A (ru) 2013-06-10
US20140134643A1 (en) 2014-05-15
JP2012525563A (ja) 2012-10-22
RU2545783C2 (ru) 2015-04-10
EP2425251B1 (en) 2017-10-25
IL215441A (en) 2015-04-30
MX2011011045A (es) 2011-11-04
KR20120005041A (ko) 2012-01-13
KR101818777B1 (ko) 2018-01-15
ES2647243T3 (es) 2017-12-20
AU2010243692B2 (en) 2015-03-05
EP2425251A1 (en) 2012-03-07
CA2757637A1 (en) 2010-11-04
WO2010124998A1 (en) 2010-11-04
IL215441A0 (en) 2011-12-29
US20120142024A1 (en) 2012-06-07
BRPI1015311B1 (pt) 2024-01-09
HK1169171A1 (en) 2013-01-18
BRPI1015311A2 (pt) 2016-04-19
CA2757637C (en) 2017-10-24
JP5689113B2 (ja) 2015-03-25
RU2545783C9 (ru) 2016-02-27
AU2010243692A1 (en) 2011-10-27
US8663942B2 (en) 2014-03-04
CN102414564B (zh) 2015-01-21
CN102414564A (zh) 2012-04-11

Similar Documents

Publication Publication Date Title
HK1257876A1 (zh) 包含蛋白酶、澱粉酶、和脂酶的組合物
HK1169171A1 (en) Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities
HRP20180854T1 (hr) Polipeptid koji ima aktivnost beta-glukozidaze i njegova uporaba
IL208373A (en) Polypeptides modified factor fvii with increased coagulation activity and various aspects based on these polypeptides
SI3252070T1 (sl) Postopek in sistem za pridobivanje botulinskega nevrotoksina
PL2588492T3 (pl) Polipeptyd mający aktywność beta-glukozydazy i jego zastosowania
SG10201502519WA (en) Amphiphilic Linear Peptide/Peptoid And Hydrogel Comprising The Same
DK2418941T3 (da) Enzymindgivelsessystemer og fremgangsmåder til fremstilling og anvendelse
EP2593469A4 (en) MODIFIED PROTEINS AND POLYPEPTIDES AND USES THEREOF
EP2419128A4 (en) MANIPULATED BOTULINUM NEUROTOXIN
IL218209A (en) Isolated peptide containing catalyzed domains of human loxl2 protein
HK1210190A1 (en) Means and methods for determination of botulinum neurotoxin biological activity
EP2496609A4 (en) CHIMERIC RSV-F POLYPEPTIDE AND VLPS ON LENTIVIREN OR ALPHA RETROVIRUS GAG BASE
HK1174688A1 (zh) 檢測糖化血紅蛋白百分比的系統和方法
EP2401264A4 (en) PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME
EP2632949A4 (en) SPECIFIC ANTIBODIES OF DIFFICULT CLOSTRIDIUM AND THEIR APPLICATIONS
EP2580345A4 (en) METHODS OF INDICATING N-TERMINAL RULE PROTEASE ACTIVITY
IL222966A0 (en) Neuregulin isoforms, neuregulin polypeptides and uses thereof
EP2468859A4 (en) NEW PROTEIN WITH B-GLUCOSIDASE ACTIVITY AND ITS USE
IL220359A (en) Recombinant histolyticum collagenases and a method for their production
RS55405B1 (sr) Varijantni, rekombinantni proteini beta-glukocerebrozidaze sa povećanom stabilnošću i povećanom zadržanom katalitičkom aktivnošću
SI2526200T1 (sl) In vitro preizkus za kvanitificiranje aktivnosti klostridijskega nevrotoksina
EP2752495A4 (en) METHOD FOR DETERMINING THE ACTIVITY OF A PROTEOLYTIC ENZYME (VARIANTS), DEVICE FOR IMPLEMENTING THE METHOD AND DIAGNOSTIC PROCEDURE
HK1146471A1 (en) Polypeptide derived from enterococcus and its use for vaccination
IL213360A0 (en) Polypeptide fragments comprising endonuclease activity and their use